In the clinic, streptokinase (trade name Streptase) is used to treat acute evolving transmural myocardial infarction, pulmonary embolism, deep vein thrombosis, arterial thrombosis, and occlusion of the arteriovenous cannula by converting plasminogen to plasmin (Leader et al., 2008). Here, PLG is linked to myocardial infarction.